Session date: 
Friday, November 11, 2016 - 8:30am to 9:30am
Location: 
Children's Hopsital of Wisconsin
9000 W. 92nd Street
Briggs and Stratton Auditorium (second floor)
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 
This educational activity is designed to highlight a new innovation, discovery, or update in medical science with an emphasis on how it applies to diagnosis, treatment, or outcomes in clinical care of the pediatric patient. The idea is to explain any basic science in such a way that will be educational and interesting to a general clinician; provide an update on clinical guidelines for diagnosis and treatment using evidence based medicine when applicable. This lecture can bring to the forefront new practice guidelines from the experts.
 
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
 
Target audience: 

Pediatrician, Psychologist, Fellow, Resident, Nurse, Other

Learning objectives: 

Participants will be able to:

Educational Objective: 

Upon completion of this session, participants should gain knowledge of the following topics in reference to acute lymphoblastic leukemia (ALL) in children and adolescents:

 1.  Epidemiology, clinical features and diagnostic evaluation
 2.  Current treatment results and key therapeutic challenges
 3.  Biology, structure, mechanism of action and results of recently completed early phase clinical trials of monoclonal antibody-based therapies and genetically engineered chimeric antigen receptor (CAR) transduced T cells.in.

Faculty & credentials: 
Planning Committee: 
Cindy Pan, MD
Robert Lane, MD
Matthew Jandrisevits, PhD
 
All persons in control of content have NO relevant financial relationships to disclose:
 

Presenters: 

Alan S. Wayne, MD, Director, Children’s Center for Cancer and Blood Diseases; Head, Division of Hematology, Oncology and Blood & Marrow Transplantation, Children’s Hospital of Los Angeles, Keck School of Medicine, University of Southern California

CME Coordinator Contact Information

Name: 
Karen Knippel
Phone number: 
+1 (414) 337-7451